ClinConnect ClinConnect Logo
Search / Trial NCT05488509

Acute Effects of Cannabis on Everyday Life Memory

Launched by WASHINGTON STATE UNIVERSITY · Aug 2, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how cannabis affects memory in everyday life. Researchers want to understand if inhaling cannabis vapor impacts different types of memory, including how we remember things we need to do, verbal tasks, and even how we recall information over time. The study is open to adults aged 18 and older who have used cannabis regularly for at least a year. Participants will need to refrain from using cannabis for at least 8 hours before their testing session.

During the study, participants will wear a wristband to monitor their physical responses and provide saliva samples to measure stress levels. They will undergo memory tests after inhaling either cannabis or a placebo (a substance with no active ingredients). The researchers hope to find that those who inhale cannabis will perform worse on memory tests compared to those who inhale the placebo. This trial is currently recruiting participants, but certain health conditions, like serious psychiatric disorders or a history of adverse reactions to cannabis, may prevent someone from taking part.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Have used cannabis at least once a week for at least one year
  • Willing to abstain from using any cannabis on the day of their scheduled testing session (minimum of 8 hours of abstinence)
  • Exclusion Criteria:
  • Diagnosis of a serious psychiatric condition (psychosis, bipolar I, panic disorder)
  • Family history of psychosis
  • Diagnosis of a neurological disorder
  • Diagnosis of a chronic medical condition (e.g., heart disease, diabetes)
  • Diagnosis of a learning disability
  • History of multiple concussions
  • History of head injury that may impact cognition
  • Being pregnant
  • Lactating
  • History of adverse experiences with cannabis (anxiety, panic attacks)
  • Use of illicit drugs in the past 6 months
  • Heavy alcohol use (\>4 drinks, \>4 times/week)
  • Smoking/nicotine use
  • BMI greater than 34

About Washington State University

Washington State University (WSU) is a leading research institution committed to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, WSU leverages its diverse expertise across various fields, including medicine, engineering, and agriculture, to address pressing health challenges. The university's clinical trial programs aim to enhance patient outcomes and contribute to the development of new therapies and interventions. By fostering a culture of scientific inquiry and integrity, WSU strives to improve public health and contribute to the global body of medical knowledge.

Locations

Pullman, Washington, United States

Patients applied

0 patients applied

Trial Officials

Ryan McLaughlin, PhD

Principal Investigator

Washington State University

Carrie Cuttler

Principal Investigator

Washington State University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials